Literature DB >> 14759418

Late results of palliative atrial switch for transposition, ventricular septal defect, and pulmonary vascular obstructive disease.

Harold M Burkhart1, Joseph A Dearani, William G Williams, Francisco J Puga, Douglas D Mair, David A Ashburn, Gary D Webb, Gordon K Danielson.   

Abstract

BACKGROUND: Palliative atrial switch (PAS) procedures that reroute pulmonary and systemic venous drainage and leave a ventricular septal defect (VSD) open have been used in the treatment of deeply cyanotic patients who have severe pulmonary vascular obstructive disease (PVOD). Palliative atrial switch is beneficial for patients with transposition of the great arteries or other complex lesions with VSD who show higher arterial oxygen saturation in the pulmonary artery than in the aorta (transposition hemodynamics/unfavorable streaming). We reviewed the early and late results of PAS (Mustard, n = 25; Senning, n = 3) in patients at two institutions.
METHODS: Between April 1965 and March 2000, PAS was performed in 28 cyanotic patients (18 male, 10 female). Median age was 10 years (range, 1 to 27). Mean preoperative pulmonary arterial pressure was 68 mm Hg (range, 30 to 121 mm Hg). Mean systemic arterial oxygen saturation was 65% (range, 47% to 80%). The majority of patients (95%) were in New York Heart Association (NYHA) functional class III or IV preoperatively.
RESULTS: Overall early mortality was 21%; for patients after 1972 (n = 23), the early mortality was 8.7%. Mean follow-up was 8.3 years (maximum 20). Mean postoperative systemic arterial oxygen saturation was increased significantly to 88% (p < 0.0001). Late survival for early survivors at 5, 10, and 15 years respectively was 84% (59%, 97%), 64% (39%, 88%), and 54% (15%, 72%). The NYHA functional class was significantly improved; 94% of late survivors (n = 17) were in functional class I or II (p = 0.002).
CONCLUSIONS: The PAS operation significantly improves systemic arterial oxygen saturation and quality of life in selected patients with transposition hemodynamics, VSD, and severe PVOD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14759418     DOI: 10.1016/S0003-4975(03)01349-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

Review 1.  Transposition of the great arteries: long-term outcome and current management.

Authors:  Daniel J Murphy
Journal:  Curr Cardiol Rep       Date:  2005-07       Impact factor: 2.931

2.  Treatment options for transposition of the great arteries with ventricular septal defect complicated by pulmonary vascular obstructive disease.

Authors:  Ali A Alakhfash; Omar R Tamimi; Abdu M Al-Khattabi; Hani K Najm
Journal:  J Saudi Heart Assoc       Date:  2009-08-05

3.  Long-term surgical results of transposition of the great arteries with left ventricular outflow tract obstruction.

Authors:  Akihisa Furuta; Masaaki Yamagishi; Goki Matsumura; Takeshi Shinkawa; Hiroshi Niinami
Journal:  J Cardiothorac Surg       Date:  2022-05-11       Impact factor: 1.637

4.  Palliative Senning in the Treatment of Congenital Heart Disease with Severe Pulmonary Hypertension.

Authors:  Juliano Gomes da Penha; Leina Zorzanelli; Antonio Augusto Barbosa-Lopes; Edimar Atik; Leonardo Augusto Miana; Carla Tanamati; Luiz Fernando Caneo; Nana Miura; Vera Demarchi Aiello; Marcelo Biscegli Jatene
Journal:  Arq Bras Cardiol       Date:  2015-08-18       Impact factor: 2.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.